CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
about
Interactions of Opioids and HIV Infection in the Pathogenesis of Chronic PainMorphine exacerbates HIV-1 Tat-induced cytokine production in astrocytes through convergent effects on [Ca(2+)](i), NF-kappaB trafficking and transcriptionModeling the Effects of Morphine on Simian Immunodeficiency Virus DynamicsTGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5Neonatal intrahippocampal HIV-1 protein Tat(1-86) injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation.Morphine increases hippocampal viral load and suppresses frontal lobe CCL5 expression in the LP-BM5 AIDS modelbeta-Chemokine production by neural and glial progenitor cells is enhanced by HIV-1 Tat: effects on microglial migration.Ibudilast (AV411), and its AV1013 analog, reduce HIV-1 replication and neuronal death induced by HIV-1 and morphineInteractions of HIV and drugs of abuse: the importance of glia, neural progenitors, and host genetic factors.Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia.Opiate addiction therapies and HIV-1 Tat: interactive effects on glial [Ca²⁺]i, oxyradical and neuroinflammatory chemokine production and correlative neurotoxicity.Toll-like receptor expression and activation in astroglia: differential regulation by HIV-1 Tat, gp120, and morphine.Fractalkine/CX3CL1 protects striatal neurons from synergistic morphine and HIV-1 Tat-induced dendritic losses and deathMorphine and gp120 toxic interactions in striatal neurons are dependent on HIV-1 strain.Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.Interactive Effects of Morphine on HIV Infection: Role in HIV-Associated Neurocognitive Disorder.Opiate drug use and the pathophysiology of neuroAIDS.HIV-1 increases TLR responses in human primary astrocytes.Morphine Tolerance and Physical Dependence Are Altered in Conditional HIV-1 Tat Transgenic Mice.Effects of Morphine on Behavioral Task Performance in SIV-Infected Rhesus Macaques.CCL5 and cytokine expression in the rat brain: differential modulation by chronic morphine and morphine withdrawal.Inhibition of GABAergic Neurotransmission by HIV-1 Tat and Opioid Treatment in the Striatum Involves μ-Opioid Receptors.A novel bivalent HIV-1 entry inhibitor reveals fundamental differences in CCR5-μ-opioid receptor interactions between human astroglia and microglia.Electro-Magnetic Nano-Particle Bound Beclin1 siRNA Crosses the Blood-Brain Barrier to Attenuate the Inflammatory Effects of HIV-1 Infection in Vitro.Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.SOLUBLE CD40 LIGAND IN DEMENTIA.CCL5-Glutamate Cross-Talk in Astrocyte-Neuron Communication in Multiple Sclerosis.Long-term morphine delivery via slow release morphine pellets or osmotic pumps: Plasma concentration, analgesia, and naloxone-precipitated withdrawal.CCR5 mediates HIV-1 Tat-induced neuroinflammation and influences morphine tolerance, dependence, and reward.
P2860
Q26768068-ECF38EFC-1CC1-4FA1-933D-C4DD3362625EQ28474433-4B8F24E2-2B35-44D8-84F4-7A402738D6D9Q28554352-303BB71E-DBE6-4367-A89D-9CCD16AD0955Q28568787-9E9D56D0-837E-4778-B0B0-0DFFEABC46C4Q30399828-26AD10E8-7600-49F8-AA0C-77B88FD40BCFQ33632272-034C7861-FA69-4431-9E2A-FA7F27D65012Q34356438-F3E2E7C8-DC71-4DF0-8883-1C9595AD578FQ34988973-A0A576E6-F928-4CCA-9156-2179A6F8FC75Q35007339-E29A30B1-FC3C-42B5-B404-80D87239F51CQ35122783-3D610FDF-4340-400A-A37D-5BEAE267A661Q35763921-8FEEFB15-881C-4451-8294-2F13279DDBABQ35779664-0777EDA3-0C6A-4928-A169-E58B350C04FDQ35779848-2A2A3CCE-8C87-4F2A-9D0C-9B5E143A8AD6Q35857045-75893408-6DB3-4C5B-9EF6-D712057F0398Q35941437-A99B3DC3-5DE1-4B3F-96FD-FFD693080801Q35996523-72204F20-3BD0-4DBB-915A-EA6F6FDFF39DQ36201412-D09945EA-6060-45DC-AEC2-7F9ED8A8C88BQ36376089-D49C8EB3-1CC8-4942-B87A-21E8B08F1C2CQ36432328-E0A2D3E0-E633-403F-A060-0925144D40B7Q36844753-1A2BD4D9-9D4F-40B4-8A80-87214C0F5CEAQ37227396-C05F884F-346C-4FC5-8C97-BD2D27A2954AQ37399037-59E90466-C782-4F11-B6EB-BAE4270607A3Q37570243-CEC861EF-36F5-4996-85A8-BC2C6FB4B691Q37590479-EA0C045F-0DD4-48BF-B0C5-0983838C53F6Q38925831-9D7AFB11-B5E7-4728-9C5A-314D25EC3C76Q39944588-16CB0E7A-E335-4684-B408-A3CB15E53378Q41471364-749C8FE1-5A35-4A9E-A29B-0A0DA5A0C1BCQ45063674-E0261819-8545-442E-8574-CD2F5FCB0819Q45073147-2629B150-2978-4907-817D-F4FE73957BBC
P2860
CCL5/RANTES gene deletion attenuates opioid-induced increases in glial CCL2/MCP-1 immunoreactivity and activation in HIV-1 Tat-exposed mice.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@en
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@nl
type
label
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@en
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@nl
prefLabel
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@en
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@nl
P2093
P2860
P1476
CCL5/RANTES gene deletion atte ...... ion in HIV-1 Tat-exposed mice.
@en
P2093
Annadora J Bruce-Keller
Kurt F Hauser
Nazira El-Hage
Pamela E Knapp
P2860
P2888
P304
P356
10.1007/S11481-008-9127-1
P577
2008-09-25T00:00:00Z